文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

一种用于全球大流行的新型低成本呼吸机:Portsmouth呼吸机

A Novel Low-Cost Ventilator for Use in a Worldwide Pandemic: The Portsmouth Ventilator.
PubMed 文献 · Crit Care Explor · 2020-12-02
一句话结论Portsmouth呼吸机是一种低成本、开源、可快速部署的气动型呼吸机,在模拟和动物实验中表现良好,成本约250美元。

基于COVID-19大流行对低成本、可快速部署呼吸机的潜在需求,研究者设计了Portsmouth呼吸机,设计标准包括:使用公众可获取的标准组件、开源兼容、能用于ARDS通气、成本尽可能低。该呼吸机为气动型,由三个电控电磁阀、压力腔、患者呼吸回路、PEEP阀和电子控制系统组成,提供混合型气动辅助控制通气,预测潮气量300-800 mL,PEEP 0-20 cm H2O,FiO2 21-100%。在两种高保真肺模拟器和猪体内模型中测试,模拟了阻塞性肺疾病和ARDS等多种病理状态,呼吸机在所有模拟场景中表现良好,体内实验显示通气和氧合不劣于标准呼吸机。所有组件公众可获取,成本约250美元。尽管功能有限,但设计简单、安全,可在呼吸机需求激增时快速量产。

要点

  • Portsmouth呼吸机为气动型,提供混合型气动辅助控制通气,预测潮气量300-800 mL,PEEP 0-20 cm H2O,FiO2 21-100%。
  • 在两种高保真肺模拟器(模拟阻塞性肺疾病和ARDS)和猪体内模型中测试,所有模拟场景表现良好。
  • 猪体内模型显示通气和氧合不劣于标准呼吸机。
  • 所有组件公众可获取,成本约250美元,设计开源,可快速量产。
  • 功能较现代呼吸机有限,但设计简单,在呼吸机需求激增时可作为应急选择。

适用人群与场景

  • 原文未提及具体适用人群与场景的纳入/排除标准;设计目标为急性呼吸窘迫综合征的通气支持。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 呼吸机设置:预测潮气量300-800 mL,PEEP 0-20 cm H2O,FiO2 21-100%。
  • 通气模式:混合型气动辅助控制通气。
  • 设计包含三个电控电磁阀、压力腔、患者呼吸回路、PEEP阀和电子控制系统,并内置多重安全元素。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:呼吸机设计与台架/动物实验测试;样本量:两种高保真肺模拟器和猪体内模型(具体数量原文未提及);无多中心信息。
  • 干预:Portsmouth呼吸机;对照:标准呼吸机(仅体内模型比较)。
  • 关键次要终点与不良事件:原文未提及。

证据类型、等级与局限

  • 证据类型:台架测试与动物实验研究(非临床试验);证据等级或推荐强度:原文未提及;局限:功能较现代呼吸机有限,未在人体中验证,样本量小(仅两种模拟器和猪模型),缺乏临床终点数据。

对床旁实践的改变

  • 在呼吸机需求激增超出供应时,可考虑快速量产的低成本开源呼吸机作为应急替代,但需注意其功能有限,不适用于常规临床通气。
  • 适用人群:原文未明确;不适用人群:原文未明确。
  • 常见陷阱:不能将动物实验中的非劣效通气和氧合结果直接推广至临床;使用前需充分测试和验证。

指南或共识出处

  • 原文未提及指南或共识出处;文献来源为Crit Care Explor。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

UNLABELLED: The ongoing severe acute respiratory syndrome coronavirus 2 or coronavirus disease 2019 pandemic has demonstrated the potential need for a low-cost, rapidly deployable ventilator. Based on this premise, we sought to design a ventilator with the following criteria: 1) standard components that are accessible to the public, 2) "open-source" compatibility to allow anyone to easily recreate the system, 3) ability to ventilate in acute respiratory distress syndrome, and 4) lowest possible cost to provide adequate oxygenation and ventilation.

DESIGN: We pursued development of a pneumatic-type ventilator. The basic design involves three electrically controlled solenoid valves, a pressure chamber, the patient breathing circuit, a positive end-expiratory pressure valve, and an electronics control system. Multiple safety elements were built into the design. The user-friendly interface allows simple control of ventilator settings. The ventilator delivers a hybrid form of pneumatic, assist-control ventilation, with predicted tidal volumes of 300-800 mL, positive end-expiratory pressure 0-20 cm H2O, and Fio2 21-100%.

MAIN RESULTS: The ventilator was extensively tested with two separate high-fidelity lung simulators and a porcine in vivo model. Both lung simulators were able to simulate a variety of pathologic states, including obstructive lung disease and acute respiratory distress syndrome. The ventilator performed well across all simulated scenarios. Similarly, a porcine in vivo model was used to assess performance in live tissue, with a specific emphasis on gas exchange. The ventilator performed well in vivo and demonstrated noninferior ventilation and oxygenation when compared with the standard ventilator.

CONCLUSIONS: The Portsmouth Ventilator was able to perform well across all simulated pathologies and in vivo. All components may be acquired by the public for a cost of approximately $250 U.S.D. Although this ventilator has limited functionality compared with modern ventilators, the simple design appears to be safe and would allow for rapid mass production if ventilator surge demand exceeded supply.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Cole JH, Hughey SB, Rector CH, et al. A Novel Low-Cost Ventilator for Use in a Worldwide Pandemic: The Portsmouth Ventilator. Crit Care Explor. 2020. PMID: 33283196. doi:10.1097/CCE.0000000000000292

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。